Identification of a serotonin/glutamate receptor complex implicated in psychosis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature

• Publication date

  2008-03-06

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1038/nature06612PMID 18297054PMCID PMC2743172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What is schizophrenia?

  2019cited by this paper
• A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis

  2007cited by this paper
• Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

  2007cited by this paper
• Common Structural Requirements for Heptahelical Domain Function in Class A and Class C G Protein-coupled Receptors*

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

  2006cited by this paper
• A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer

  2006cited by this paper
• Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis

  2006cited by this paper
• The Neurochemical Circuitry of Schizophrenia

  2006cited by this paper
• Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

  2005cited by this paper
• Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

  2005cited by this paper
• Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization

  2005cited by this paper
• Metabotropic glutamate 2/3 receptors as drug targets.

  2004cited by this paper
• Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions.

  2004cited by this paper
• Atomic-force microscopy: Rhodopsin dimers in native disc membranes

  2003cited by this paper
• Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy.

  2003cited by this paper
• Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes*

  2003cited by this paper
• Structure of bovine rhodopsin in a trigonal crystal form.

  2003cited by this paper
• Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

  2003cited by this paper
• The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice

  2003cited by this paper
• Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance.

  2003cited by this paper
• Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia

  2003cited by this paper
• Discovering risperidone: the LSD model of psychopathology

  2003cited by this paper
• Efficacy at g-protein-coupled receptors

  2002cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Schizophrenia: Diverse Approaches to a Complex Disease

  2002cited by this paper
• Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

  2002cited by this paper
• Quantitative stoichiometry of G-proteins activated by mu-opioid receptors in postmortem human brain.

  2002cited by this paper
• G-protein coupled receptor

  2001cited by this paper
• [H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

  2001cited by this paper
• [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.

  2001cited by this paper
• A systems model of altered consciousness: integrating natural and drug-induced psychoses.

  2001cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

  2000cited by this paper
• Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.

  2000cited by this paper
• Extreme C Terminus of G Protein α-Subunits Contains a Site That Discriminates between Gi-coupled Metabotropic Glutamate Receptors*

  1998cited by this paper
• Serotonergic basis of antipsychotic drug effects in schizophrenia.

  1998cited by this paper
• Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

  1998cited by this paper
• Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

  1997cited by this paper
• Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis

  1997cited by this paper
• Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

  1995cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Basic local alignment search tool.

  1990cited by this paper

• Allosteric activation of the glutamate receptor mGlu2 by the serotonin receptor 5-HT2A.

  2026cites this paper
• Lack of striatal-enriched protein tyrosine phosphatase affected the serotonin system, behavior, and brain morphology in mice

  2026cites this paper
• Glutamate Metabotropic Receptors-Linked Postsynaptic Density Proteins: An Emergent Hub for Antipsychotics' Regulation of Synaptic Plasticity and Metaplasticity.

  2026cites this paper
• Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling.

  2026cites this paper
• Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2

  2025cites this paper
• Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons

  2025cites this paper
• A neuroscientific model of near-death experiences

  2025cites this paper
• CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

  2025cites this paper
• Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors.

  2025cites this paper
• Genetic Inactivation of the Serotonin Transporter Dysregulates Expression of Neurotransmission Genes and Genome‐Wide DNA Methylation Levels in the Medial Prefrontal Cortex of Male Rats During Postnatal Development

  2025cites this paper
• GPCR Heterodimers: Implications for Biased Signaling.

  2025cites this paper
• Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure

  2025cites this paper
• Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor.

  2025cites this paper
• Decoding Multifaceted Roles of Sleep-Related Genes as Molecular Bridges in Chronic Disease Pathogenesis

  2025cites this paper
• Role of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Psychedelics in the Treatment of Major Depressive Disorder: A Perspective on Mechanistic Insight and Current Status.

  2025cites this paper
• Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex

  2025cites this paper
• Psychedelic Experiences Elicited by Serotonergic Psychedelics; Molecular Mechanisms and Functional Connectivity Changes in /the Brain.

  2025cites this paper
• Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats

  2025cites this paper
• Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset.

  2025cites this paper
• The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity

  2025cites this paper
• Biased Signaling in Psychedelic Action.

  2025cites this paper
• Translation-independent association of mRNAs that encode protomers of the 5-HT2A-mGlu2 receptor complex

  2025cites this paper
• GABA-independent activation of GABAB receptor by mechanical forces

  2025cites this paper
• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery

  2025cites this paper
• Beyond dopamine: Novel strategies for schizophrenia treatment

  2024cites this paper
• Computational Methods to Target Protein-Protein Interactions.

  2024cites this paper
• Do the therapeutic effects of psilocybin involve actions in the gut?

  2024cites this paper
• Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

  2024cites this paper
• G protein-coupled receptor-receptor interactions in gonadal physiology.

  2024cites this paper
• Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor

  2024cites this paper
• Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis

  2024cites this paper
• The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction

  2024influential citation
• Robust Methods For Quantifying Neuronal Morphology And Molecular Signaling Reveal That Psychedelics Do Not Induce Neuroplasticity

  2024cites this paper
• Cannabinoids and monoaminergic system: implications for learning and memory

  2024cites this paper
• The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review

  2024cites this paper
• The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders

  2024cites this paper
• TrkB receptor interacts with mGlu2 receptor and mediates antipsychotic-like effects of mGlu2 receptor activation in the mouse

  2024cites this paper
• Possible roles of heteroreceptor complexes in excitotoxic processes

  2024cites this paper
• Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.

  2024cites this paper
• Unveiling the complexity of G protein-coupled receptor heteromers: advances in live cell imaging technologies and biochemical methods

  2024cites this paper
• Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions

  2024cites this paper
• The World of GPCR dimers – Mapping dopamine receptor D2 homodimers in different activation states and configuration arrangements

  2023cites this paper
• Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders

  2023cites this paper
• Low prepulse inhibition predicts lower social interaction, impaired spatial working memory, reference memory and cognitive flexibility in genetically heterogeneous rats.

  2023cites this paper
• Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats

  2023cites this paper
• [An effect of antipsychotic and anticholinergic treatment on cognitive function in patients with schizophrenia].

  2023cites this paper
• Psychedelics: preclinical insights provide directions for future research

  2023cites this paper
• Asymmetric activation of GABAB and metabotropic glutamate receptors.

  2023cites this paper
• Epigenetic regulation of metabotropic glutamate 2/3 receptors: Potential role for ultra-resistant schizophrenia?

  2023cites this paper
• Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features

  2023cites this paper
• Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

  2023cites this paper
• GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders.

  2023cites this paper
• Automated Detection of Psychedelic-Induced Head-Twitch Response in Mice.

  2023cites this paper
• Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics

  2023cites this paper
• Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

  2023cites this paper
• Chronic toxicity of broflanilide in Daphnia magna: changes in molting, behavior, and gene expression

  2023cites this paper
• Molecular Mechanism of Obsessive-Compulsive Disorder

  2023cites this paper
• A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine

  2023cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use.

  2023cites this paper
• Metabotropic glutamate receptors in Parkinson's disease.

  2023cites this paper
• G protein coupled receptors as targets for transformative neuropsychiatric therapeutics.

  2023cites this paper
• Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT2AR-Mediated Gs Signaling Pathway

  2023cites this paper
• A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics

  2023cites this paper
• The Effects of Psychedelics on Neuronal Physiology.

  2023cites this paper
• Therapeutic mechanisms of psychedelics and entactogens

  2023cites this paper
• Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.

  2023cites this paper
• Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG

  2023cites this paper
• Metamodulation of presynaptic NMDA receptors: New perspectives for pharmacological interventions.

  2023cites this paper
• A suite of engineered mice for interrogating psychedelic drug actions

  2023cites this paper
• Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia-related Symptoms

  2023cites this paper
• Modulation of circuit oscillations in the rat anterior cingulate cortex (ACC) in vitro by mGlu2 metabotropic glutamate receptors and alleviation of the effects of phencyclidine-induced NMDA-receptor hypofunction.

  2023cites this paper
• Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors.

  2023cites this paper
• Metabotropic glutamate receptors and cognition: From underlying plasticity and neuroprotection to cognitive disorders and therapeutic targets.

  2023cites this paper
• A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression

  2023cites this paper
• The crosstalk between 5-HT2AR and mGluR2 in schizophrenia.

  2023cites this paper
• Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.

  2023cites this paper
• 5-HT 2A -mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: a 5-HT 2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis

  2022cites this paper
• The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference

  2022cites this paper
• GPCR heteromers: An overview of their classification, function and physiological relevance

  2022cites this paper
• Investigation of differentially expressed genes and dysregulated pathways involved in multiple sclerosis.

  2022cites this paper
• Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.

  2022cites this paper
• Fast-Scanning Potential-Gated Organic Electrochemical Transistors for Highly Sensitive Sensing of Dopamine in Living Rat Brain.

  2022cites this paper
• New Paradigms of Old Psychedelics in Schizophrenia

  2022cites this paper
• Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice

  2022cites this paper
• Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism

  2022cites this paper
• Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

  2022cites this paper
• Perspectives of Presynaptic Autoreceptors and Presynaptic Heteroreceptors in the Mechanism of Neurotransmission

  2022cites this paper
• Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents

  2022cites this paper
• Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia

  2022cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• Abnormal synaptic plasticity and impaired cognition in schizophrenia

  2022cites this paper
• N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

  2022cites this paper
• Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model

  2022cites this paper
• Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

  2022cites this paper
• Transcriptomically-Guided Pharmacological Experiments in Neocortical and Hippocampal NPY-Positive GABAergic Interneurons

  2022cites this paper
• In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR

  2022cites this paper
• Serum levels of olanzapine are associated with acute cognitive effects in bipolar disorder.

  2022cites this paper
• Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects.

  2022cites this paper
• The role of thalamic group II mGlu receptors in health and disease

  2022cites this paper